Patients with three or more primary melanomas: clinical-epidemiological study

Kód výsledku v IS VaVaI

RIV/00669806:_____/23:10465079 - isvavai.cz

Nalezeny alternativní kódy

RIV/00216208:11140/23:10465079

Výsledek na webu

https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7-Zih~a1Da

DOI - Digital Object Identifier

10.1016/j.abd.2022.12.003

Jazyk výsledku

angličtina

Název v původním jazyce

Patients with three or more primary melanomas: clinical-epidemiological study

Popis výsledku v původním jazyce

The incidence of malignant melanoma is growing worldwide and melanoma is responsible for most skin cancer-related deaths. Patients with melanoma undergo follow-up visits mainly to avoid disease progression. Moreover, the diagnosis of melanoma has been reported to be a risk factor for subsequent melanoma dvelopment. Tha mojority of parients with Multiple Primary Melanomas (MPM) have two primary tumors and only a small part of themhas three or more Primary Melanomas (MPM) have two primary tumors and only a small part of them has three or more Primary Melanomas (3PM). The literature is almost exclusively focused on the group of MPM patients as a whole and odes not address patients with more than two primary tumors.

Název v anglickém jazyce

Patients with three or more primary melanomas: clinical-epidemiological study

Popis výsledku anglicky

The incidence of malignant melanoma is growing worldwide and melanoma is responsible for most skin cancer-related deaths. Patients with melanoma undergo follow-up visits mainly to avoid disease progression. Moreover, the diagnosis of melanoma has been reported to be a risk factor for subsequent melanoma dvelopment. Tha mojority of parients with Multiple Primary Melanomas (MPM) have two primary tumors and only a small part of themhas three or more Primary Melanomas (MPM) have two primary tumors and only a small part of them has three or more Primary Melanomas (3PM). The literature is almost exclusively focused on the group of MPM patients as a whole and odes not address patients with more than two primary tumors.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30216 - Dermatology and venereal diseases

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Anais Brasileiros de Dermatologia

ISSN

0365-0596

e-ISSN

1806-4841

Svazek periodika

89

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

BR - Brazilská federativní republika

Počet stran výsledku

5

Strana od-do

684-688

Kód UT WoS článku

001051749500001

EID výsledku v databázi Scopus

2-s2.0-85159062198